Polymorphism of the lipopolysaccharide receptor (CD14) and myocardial infarction: New evidence for a role of gram-negative bacterial infection?

Circulation

Volumn 99, Issue 25, 1999, Pages 3210-3212

  Kane, J P ^a   Havel, R J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Editorials; Epidemiology; Genetics; Immune system; Myocardial infarction

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CD14 ANTIGEN; CELL RECEPTOR;

ADULT; ALLELE; ANTIGEN EXPRESSION; ATHEROGENESIS; CARDIOVASCULAR RISK; CONTROLLED STUDY; CZECHOSLOVAKIA; DISEASE SEVERITY; EDITORIAL; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; GERMANY; GRAM NEGATIVE INFECTION; HEART INFARCTION; HISTOPATHOLOGY; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; RECEPTOR GENE;

EID: 0033614834     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.99.25.3210     Document Type: Editorial

References (25)